Metabolomic and Lipidomic Analysis Predicts Immunotherapy-related Adverse Events in Gastric Cancer Patients

Clinical trial NCT06915389 · RECRUITING

Trial details

NCT number: NCT06915389
Sponsor: Qinghai Red Cross Hospital
Status: RECRUITING
Study type: OBSERVATIONAL

Gastric Cancer Immunotherapy Adverse Event Metabonomics Lipidomics

Start date: 2025-02-22
Primary completion: 2026-12-31
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.